- Parental and other factors associated with hydroxyurea use for pediatric sickle cell diseaseSuzette O Oyeku
Department of Pediatrics, Division of General Pediatrics, Children s Hospital at Montefiore, Albert Einstein College of Medicine of Yeshiva University, Bronx, New York 10467, USA
Pediatr Blood Cancer 60:653-8. 2013..Hydroxyurea (HU) is highly effective treatment for sickle cell disease (SCD). While pediatric use of HU is accepted clinical practice, barriers to use may impede its potential benefit...
- Primary care clinicians' knowledge and confidence about newborn screening for sickle cell disease: randomized assessment of educational strategiesSuzette O Oyeku
Division of General Pediatrics, The Children s Hospital at Montefiore, Bronx, New York, USA
J Natl Med Assoc 102:676-82. 2010..We assessed clinicians' knowledge, confidence, and practices regarding hemoglobinopathy newborn screening, and the effect of mailed educational materials vs interactive seminar on knowledge and confidence...